TMEM100 negatively regulated by microRNA-106b facilitates cellular apoptosis by suppressing survivin expression in NSCLC.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8136
- By:
- Publication type:
- Article
Works matching IS 1021335X AND DT 2021 AND VI 46 AND IP 2
Results: 34
1
2
Abnormal function of telomere protein TRF2 induces cell mutation and the effects of environmental tumor-promoting factors.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8135
- By:
- Publication type:
- Article
3
EphA8 inhibits cell apoptosis via AKT signaling and is associated with poor prognosis in breast cancer.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8134
- By:
- Publication type:
- Article
4
Tumorigenic effect of TERT and its potential therapeutic target in NSCLC.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8133
- By:
- Publication type:
- Article
5
lncRNA MALAT1/miR-26a/26b/ST8SIA4 axis mediates cell invasion and migration in breast cancer cell lines.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8132
- By:
- Publication type:
- Article
6
RORβ suppresses the stemness of gastric cancer cells by downregulating the activity of the Wnt signaling pathway.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8131
- By:
- Publication type:
- Article
7
MicroRNA-154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8130
- By:
- Publication type:
- Article
8
Long non-coding RNA MCM3AP-AS1 drives ovarian cancer progression via the microRNA-143-3p/TAK1 axis.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8129
- By:
- Publication type:
- Article
9
Value of methylation markers in colorectal cancer.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8128
- By:
- Publication type:
- Article
10
TMEM229A suppresses non-small cell lung cancer progression via inactivating the ERK pathway.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8127
- By:
- Publication type:
- Article
11
miR-29a inhibits human retinoblastoma progression by targeting STAT3.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8126
- By:
- Publication type:
- Article
12
Synthetic miR-145 mimic inhibits multiple myeloma cell growth in vitro and in vivo.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8125
- By:
- Publication type:
- Article
13
Anti-HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8124
- By:
- Publication type:
- Article
14
Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8123
- By:
- Publication type:
- Article
15
Endothelin-1 induces changes in the expression levels of steroidogenic enzymes and increases androgen receptor and testosterone production in the PC3 prostate cancer cell line.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8122
- By:
- Publication type:
- Article
16
Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19-positive malignancies.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8121
- By:
- Publication type:
- Article
17
Egr-1 inhibits colon cancer cell proliferation, migration and invasion via regulating CDKL1 at the transcriptional level.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8120
- By:
- Publication type:
- Article
18
Nuclear IGF1R interacts with NuMA and regulates 53BP1-dependent DNA double-strand break repair in colorectal cancer.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8119
- By:
- Publication type:
- Article
19
MicroRNA-10b modulates cisplatin tolerance by targeting p53 directly in lung cancer cells.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8118
- By:
- Publication type:
- Article
20
Dehydrocrenatidine extracted from Picrasma quassioides induces the apoptosis of nasopharyngeal carcinoma cells through the JNK and ERK signaling pathways.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8117
- By:
- Publication type:
- Article
21
Long noncoding RNA SLC9A3-AS1 increases E2F6 expression by sponging microRNA-486-5p and thus facilitates the oncogenesis of nasopharyngeal carcinoma.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8116
- By:
- Publication type:
- Article
22
Long non-coding RNA 00858 knockdown alleviates bladder cancer via regulation of the miR-3064-5p/CTGF axis.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8115
- By:
- Publication type:
- Article
23
METTL3-mediated m6A modification of Bcl-2 mRNA promotes non-small cell lung cancer progression.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8114
- By:
- Publication type:
- Article
24
miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8113
- By:
- Publication type:
- Article
25
miR-375/Yes-associated protein axis regulates IL-6 and TGF-β expression, which is involved in the cisplatin-induced resistance of liver cancer cells.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8112
- By:
- Publication type:
- Article
26
Association between oral microflora and gastrointestinal tumors.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8111
- By:
- Publication type:
- Article
27
TOOLBOX: Strep-Tagged nano-assemblies of antibody-drug-conjugates (ADC) for modular and conditional cancer drugging.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8110
- By:
- Publication type:
- Article
28
The role of immunotherapy and molecular-targeted therapy in the treatment of melanoma.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG
- By:
- Publication type:
- Article
29
RHBDD2-WWOX protein interaction during proliferative and differentiated stages in normal and breast cancer cells.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8108
- By:
- Publication type:
- Article
30
MicroRNA-124 suppresses the migration and invasion of osteosarcoma cells via targeting ROR2-mediated non-canonical Wnt signaling.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8107
- By:
- Publication type:
- Article
31
MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8106
- By:
- Publication type:
- Article
32
RUNX2/miR-31/SATB2 pathway in nickel-induced BEAS-2B cell transformation.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8105
- By:
- Publication type:
- Article
33
Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the ERK and p53/HDM2 signaling pathways to promote the survival, proliferation and migration of non-small cell lung cancer cells.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8104
- By:
- Publication type:
- Article
34
miR-133a inhibits cervical cancer growth by targeting EGFR.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG
- By:
- Publication type:
- Article